The Filings Report

Roivant Sciences Ltd. Common Shares insider trading

ROIVfinancial statementsForm 4 filings on EDGAR408 transactions since Nov 1, 2024

From August 4, 2026 to November 1, 2026, 0 insiders at Roivant Sciences Ltd. Common Shares bought $0 of stock in the open market, and 4 sold $67M. Officers and directors accounted for $0 of purchases and $67M of sales. The last reported transaction was an open-market sale by Venker Eric on October 28, 2026.

The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 30, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.

Stock price and insider activity

Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.

ROIV daily priceSplit-adjusted prices in US dollars

Bought $0Sold $67MAug 4, 2026 – Nov 1, 2026

Oct 30, 2026O $37.11 · H $37.94 · L $36.78 · C $36.91Bought $0 (0)Sold $0 (0)
$32$35$38$40$432026-08-04: open $33.74, high $34.70, low $33.45, close $34.592026-08-05: open $34.89, high $35.56, low $34.35, close $34.602026-08-06: open $33.11, high $35.37, low $33.11, close $35.122026-08-07: open $35.88, high $36.44, low $35.62, close $36.342026-08-10: open $36.05, high $36.78, low $35.68, close $35.782026-08-11: open $36.00, high $36.00, low $34.56, close $35.252026-08-12: open $35.22, high $36.50, low $35.22, close $36.162026-08-13: open $36.70, high $36.70, low $35.78, close $36.282026-08-14: open $36.14, high $36.49, low $35.87, close $36.202026-08-17: open $36.22, high $37.19, low $35.65, close $36.242026-08-18: open $35.91, high $37.46, low $35.86, close $37.372026-08-19: open $37.83, high $37.97, low $36.75, close $37.402026-08-20: open $36.91, high $37.55, low $36.68, close $36.842026-08-21: open $37.03, high $37.18, low $36.23, close $36.302026-08-24: open $36.22, high $36.57, low $35.71, close $36.362026-08-25: open $36.82, high $37.29, low $36.31, close $36.472026-08-26: open $36.93, high $36.93, low $36.32, close $36.752026-08-27: open $36.85, high $37.81, low $36.50, close $37.582026-08-28: open $37.01, high $37.13, low $34.69, close $34.712026-08-31: open $34.83, high $35.34, low $34.02, close $34.642026-09-01: open $34.64, high $34.95, low $34.26, close $34.522026-09-02: open $34.64, high $35.04, low $33.43, close $34.182026-09-03: open $34.35, high $34.43, low $33.67, close $34.412026-09-04: open $34.20, high $35.15, low $33.88, close $34.932026-09-08: open $39.98, high $42.50, low $38.41, close $41.482026-09-09: open $41.39, high $42.28, low $41.08, close $41.812026-09-10: open $41.27, high $41.41, low $40.22, close $40.942026-09-11: open $41.22, high $41.83, low $40.51, close $40.822026-09-14: open $40.64, high $41.60, low $40.44, close $41.022026-09-15: open $41.14, high $41.14, low $39.22, close $39.502026-09-16: open $39.77, high $40.45, low $39.17, close $39.572026-09-17: open $40.45, high $40.97, low $39.50, close $39.982026-09-18: open $40.11, high $40.71, low $39.72, close $39.772026-09-21: open $39.02, high $39.90, low $38.72, close $38.992026-09-22: open $38.73, high $39.17, low $38.11, close $38.222026-09-23: open $38.00, high $38.47, low $36.78, close $36.822026-09-24: open $36.64, high $36.75, low $35.91, close $36.132026-09-25: open $35.98, high $36.19, low $35.52, close $35.802026-09-28: open $35.65, high $37.25, low $35.28, close $36.982026-09-29: open $37.03, high $37.35, low $35.75, close $36.502026-09-30: open $36.77, high $36.96, low $36.23, close $36.572026-10-01: open $36.35, high $36.79, low $35.44, close $35.502026-10-02: open $35.61, high $36.00, low $35.19, close $35.722026-10-05: open $35.98, high $36.33, low $35.25, close $35.782026-10-06: open $35.86, high $36.34, low $34.75, close $35.532026-10-07: open $35.22, high $35.49, low $34.63, close $34.752026-10-08: open $34.28, high $34.56, low $33.32, close $34.212026-10-09: open $34.24, high $35.59, low $34.15, close $35.442026-10-12: open $34.92, high $35.41, low $34.55, close $34.592026-10-13: open $34.44, high $34.92, low $33.26, close $33.352026-10-14: open $33.14, high $34.09, low $33.00, close $33.622026-10-15: open $33.82, high $34.36, low $33.70, close $34.042026-10-16: open $34.12, high $34.12, low $33.23, close $33.532026-10-19: open $33.78, high $35.14, low $33.60, close $34.702026-10-20: open $35.00, high $35.52, low $34.38, close $34.922026-10-21: open $38.15, high $38.49, low $35.99, close $36.802026-10-22: open $36.68, high $38.49, low $36.68, close $37.452026-10-23: open $37.18, high $37.42, low $36.36, close $36.492026-10-26: open $36.66, high $36.91, low $35.66, close $36.052026-10-27: open $35.94, high $36.83, low $35.80, close $36.542026-10-28: open $36.43, high $37.13, low $36.13, close $37.112026-10-29: open $37.44, high $37.97, low $37.29, close $37.522026-10-30: open $37.11, high $37.94, low $36.78, close $36.91Insider purchases / sales · USD$20M$0−$20M2026-08-14: 0 purchases ($0), 1 sales ($9M)2026-08-17: 0 purchases ($0), 1 sales ($10M)2026-08-18: 0 purchases ($0), 2 sales ($5M)2026-08-19: 0 purchases ($0), 1 sales ($6M)2026-08-20: 0 purchases ($0), 1 sales ($653K)2026-08-21: 0 purchases ($0), 1 sales ($5M)2026-08-28: 0 purchases ($0), 2 sales ($7M)2026-09-08: 0 purchases ($0), 1 sales ($798K)2026-09-15: 0 purchases ($0), 4 sales ($399K)2026-09-30: 0 purchases ($0), 1 sales ($7M)2026-10-01: 0 purchases ($0), 2 sales ($641K)2026-10-20: 0 purchases ($0), 2 sales ($7M)2026-10-28: 0 purchases ($0), 1 sales ($7M)Aug 4Aug 26Sep 17Oct 9Oct 30

purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.

Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.

Every transaction

408 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 28, 2026Venker EricPresident & Immunovant CEOopen-market sale10b5-1200,000$36.59$7M1MOct 30, 2026
Oct 23, 2026Oren IlanDirectoraward810$0.00—124,490Oct 27, 2026
Oct 23, 2026Epperly Melissa B,Directoraward513$0.00—15,467Oct 27, 2026
Oct 23, 2026Epperly Melissa B,Directortax withholding116$36.49$4K15,351Oct 27, 2026
Oct 23, 2026Momtazee James CDirectoraward383$0.00—112,342Oct 27, 2026
Oct 23, 2026Momtazee James CDirectortax withholding77$36.49$3K112,265Oct 27, 2026
Oct 20, 2026Venker EricPresident & Immunovant CEOopen-market sale10b5-1185,856$35.09$7M1MOct 22, 2026
Oct 20, 2026Venker EricPresident & Immunovant CEOopen-market sale10b5-114,144$35.42$501K1MOct 22, 2026
Oct 16, 2026Sukhatme MayukhPresident & CIO, Directortax withholding19,976$33.53$670K19MOct 20, 2026
Oct 16, 2026Gline MatthewCEO, Directortax withholding34,638$33.53$1M17MOct 20, 2026
Oct 1, 2026Roivant Sciences Ltd.Director, 10% ownerdisposition to issuer9M$5.00$45M30MOct 5, 2026
Oct 1, 2026Epperly Melissa B,Directoroption exercise17,750$4.46$79K32,704Oct 5, 2026
Oct 1, 2026Epperly Melissa B,Directoropen-market sale10b5-116,850$36.08$608K15,854Oct 5, 2026
Oct 1, 2026Epperly Melissa B,Directoropen-market sale10b5-1900$36.57$33K14,954Oct 5, 2026
Sep 30, 2026Gline MatthewCEO, Directortax withholding76,171$36.57$3M17MOct 2, 2026
Sep 30, 2026Torti FrankPresident and Vant Chairtax withholding40,309$36.57$1M13MOct 2, 2026
Sep 30, 2026Sukhatme MayukhPresident & CIO, Directortax withholding46,879$36.57$2M19MOct 2, 2026
Sep 30, 2026Venker EricPresident & Immunovant CEOoption exercise200,000$3.85$770K2MOct 2, 2026
Sep 30, 2026Venker EricPresident & Immunovant CEOopen-market sale10b5-1200,000$36.62$7M2MOct 2, 2026
Sep 20, 2026Humes JenniferChief Accounting Officertax withholding3,880$39.77$154K106,419Sep 22, 2026
Sep 20, 2026Pulik RichardCFOtax withholding2,129$39.77$85K269,681Sep 22, 2026
Sep 16, 2026Manchester Keith SDirectoraward5,054$0.00—2MSep 18, 2026
Sep 16, 2026Gold Daniel AllenDirectoraward5,054$0.00—9MSep 18, 2026
Sep 16, 2026Oren IlanDirectoraward5,054$0.00—123,680Sep 18, 2026
Sep 16, 2026Momtazee James CDirectoraward5,054$0.00—111,959Sep 18, 2026
Sep 16, 2026Fitzgerald MeghanDirectoraward5,054$0.00—41,162Sep 18, 2026
Sep 16, 2026Epperly Melissa B,Directoraward5,054$0.00—14,954Sep 18, 2026
Sep 15, 2026Epperly Melissa B,Directoropen-market sale10b5-14,338$39.65$172K10,500Sep 17, 2026
Sep 15, 2026Epperly Melissa B,Directoropen-market sale10b5-1600$40.38$24K9,900Sep 17, 2026
Sep 15, 2026Fitzgerald MeghanDirectoropen-market sale10b5-14,712$39.68$187K36,508Sep 17, 2026
Sep 15, 2026Fitzgerald MeghanDirectoropen-market sale10b5-1400$40.45$16K36,108Sep 17, 2026
Sep 10, 2026Gold Daniel AllenDirectortax withholding5,133$40.94$210K9MSep 14, 2026
Sep 10, 2026Oren IlanDirectortax withholding2,378$40.94$97K118,626Sep 14, 2026
Sep 10, 2026Epperly Melissa B,Directortax withholding2,179$40.94$89K14,838Sep 14, 2026
Sep 10, 2026Fitzgerald MeghanDirectortax withholding1,743$40.94$71K41,220Sep 14, 2026
Sep 10, 2026Momtazee James CDirectortax withholding2,905$40.94$119K106,905Sep 14, 2026
Sep 8, 2026Fitzgerald MeghanDirectoroption exercise20,000$8.80$176K62,963Sep 10, 2026
Sep 8, 2026Fitzgerald MeghanDirectoropen-market sale10b5-120,000$39.90$798K42,963Sep 10, 2026
Aug 28, 2026Venker EricPresident & Immunovant CEOoption exercise200,000$3.85$770K2MSep 1, 2026
Aug 28, 2026Venker EricPresident & Immunovant CEOopen-market sale10b5-1166,182$35.63$6M2MSep 1, 2026
Aug 28, 2026Venker EricPresident & Immunovant CEOopen-market sale10b5-133,818$36.44$1M2MSep 1, 2026
Aug 21, 2026Sukhatme MayukhPresident & CIO, Directoroption exercise144,756$3.85$557K19MAug 21, 2026
Aug 21, 2026Sukhatme MayukhPresident & CIO, Directoropen-market sale144,756$36.48$5M19MAug 21, 2026
Aug 20, 2026Pulik RichardCFOtax withholding5,749$36.84$212K271,810Aug 24, 2026
Aug 20, 2026Venker EricPresident & Immunovant CEOtax withholding13,909$36.84$512K2MAug 24, 2026
Aug 20, 2026Sukhatme MayukhPresident & CIO, Directoroption exercise17,519$3.85$67K19MAug 21, 2026
Aug 20, 2026Sukhatme MayukhPresident & CIO, Directoropen-market sale17,519$37.30$653K19MAug 21, 2026
Aug 19, 2026Sukhatme MayukhPresident & CIO, Directoroption exercise172,899$3.85$666K19MAug 21, 2026
Aug 19, 2026Sukhatme MayukhPresident & CIO, Directoropen-market sale172,899$37.17$6M19MAug 21, 2026
Aug 18, 2026Sukhatme MayukhPresident & CIO, Directoroption exercise105,141$3.85$405K19MAug 18, 2026

Who the insiders are

Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.

InsiderRoleLast transactionKindShares heldBought, 12 monthsSold, 12 monthsSales under a plan
Manchester Keith SDirectorSep 16, 2026award2M—$154M (20)0 of 20
Gold Daniel AllenDirectorSep 16, 2026award9M—$147M (19)0 of 19
QVT Financial LP—Jun 30, 2026open-market sale——$147M (19)0 of 19
Sukhatme MayukhPresident & CIO, DirectorOct 16, 2026tax withholding19M—$109M (13)0 of 13
Ramaswamy Vivek10% ownerDec 15, 2025other34M—$106M (6)0 of 6
Venker EricPresident & Immunovant CEOOct 28, 2026open-market sale1M—$84M (18)16 of 18
Torti FrankPresident and Vant ChairSep 30, 2026tax withholding13M—$82M (3)3 of 3
Gline MatthewCEO, DirectorOct 16, 2026tax withholding17M—$46M (4)0 of 4
Pulik RichardCFOSep 20, 2026tax withholding269,681—$9M (2)0 of 2
Fitzgerald MeghanDirectorSep 16, 2026award41,162—$3M (5)4 of 5
Epperly Melissa B,DirectorOct 23, 2026award15,467—$3M (7)6 of 7
Humes JenniferChief Accounting OfficerSep 20, 2026tax withholding106,419—$384K (1)0 of 1
Momtazee James CDirectorOct 23, 2026award112,342———
Oren IlanDirectorOct 23, 2026award124,490———
Kumar RakhiChief Accounting OfficerFeb 20, 2025tax withholding162,306———
Roivant Sciences Ltd.Director, 10% ownerOct 1, 2026disposition to issuer30M———

Questions

Are Roivant Sciences Ltd. Common Shares insiders buying or selling?

Over the twelve months to November 1, 2026, 12 insiders at Roivant Sciences Ltd. Common Shares sold $892M of stock in the open market ($639M by officers and directors), and no insider bought. Net, insiders sold $892M. Only open-market purchases and sales are counted.

Who sold the most Roivant Sciences Ltd. Common Shares stock in the last year?

Manchester Keith S (Director) sold $154M in 20 open-market sales over the twelve months to November 1, 2026.

Do Roivant Sciences Ltd. Common Shares executives sell under 10b5-1 plans?

29 of the 117 open-market sales in the last twelve months (25%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.

What counts as insider buying here?

Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.

More on Roivant Sciences Ltd. Common Shares

From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.